| Literature DB >> 22693639 |
Matthias Nagel1, Andreas Sprenger, Susanne Steinlechner, Ferdinand Binkofski, Rebekka Lencer.
Abstract
Smooth pursuit eye movements (SPEM) are needed to keep the retinal image of slowly moving objects within the fovea. Depending on the task, about 50%-80% of patients with schizophrenia have difficulties in maintaining SPEM. We designed a study that comprised different target velocities as well as testing for internal (extraretinal) guidance of SPEM in the absence of a visual target. We applied event-related fMRI by presenting four velocities (5, 10, 15, 20°/s) both with and without intervals of target blanking. 17 patients and 16 healthy participants were included. Eye movements were registered during scanning sessions. Statistical analysis included mixed ANOVAs and regression analyses of the target velocity on the Blood Oxygen Level Dependency (BOLD) signal. The main effect group and the interaction of velocity×group revealed reduced activation in V5 and putamen but increased activation of cerebellar regions in patients. Regression analysis showed that activation in supplementary eye field, putamen, and cerebellum was not correlated to target velocity in patients in contrast to controls. Furthermore, activation in V5 and in intraparietal sulcus (putative LIP) bilaterally was less strongly correlated to target velocity in patients than controls. Altered correlation of target velocity and neural activation in the cortical network supporting SPEM (V5, SEF, LIP, putamen) implies impaired transformation of the visual motion signal into an adequate motor command in patients. Cerebellar regions seem to be involved in compensatory mechanisms although cerebellar activity in patients was not related to target velocity.Entities:
Mesh:
Year: 2012 PMID: 22693639 PMCID: PMC3367930 DOI: 10.1371/journal.pone.0038494
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Regression analysis of target velocity and BOLD.
|
|
| |||||||||
| upper coordinates: healthycontrols lower coordinates :patients | x | y | z | t-value | P (FWE) | x | y | z | t-value | P (FWE) |
| Calcarine fissure right | 12 | −72 | −3 | 11.63 | <0.0001 | 9 | −66 | 3 | 12.5 | <0.0001 |
| 12 | −78 | 6 | 6.6 | <0.0001 | 18 | −60 | 0 | 5.74 | 0.002 | |
| Calcarine fissure left | −12 | −66 | 3 | 9.68 | <0.0001 | −12 | −72 | 6 | 16.23 | <0.0001 |
| −3 | −78 | 6 | 6.53 | <0.0001 | −21 | −57 | 3 | 6.96 | <0.0001 | |
| V5 (hMT/hMST) right | 45 | −63 | 3 | 7.47 | <0.0001 | 51 | −63 | 0 | 9.16 | <0.0001 |
| 42 | −63 | 3 | 4.27 | 0.029 | 48 | −60 | 9 | 5.65 | 0.002 | |
| V5 (hMT/hMST) left | −39 | −72 | 3 | 4.86 | 0.008 | −48 | −69 | 6 | 7.45 | <0.0001 |
| −51 | −72 | 0 | 3.61 | 0.082 | −39 | −78 | 0 | 5.90 | 0.001 | |
| Intraparietal sulcus right(putative LIP) | 21 | −54 | 51 | 5.48 | 0.004 | 21 | −63 | 57 | 8.78 | <0.0001 |
| 30 | −57 | 57 | 3.97 | 0.047 | 18 | −63 | 51 | 3.67 | 0.063 | |
| Intraparietal sulcus left(putative LIP) | −24 | −60 | 63 | 5.03 | 0.009 | −12 | −66 | 54 | 6.45 | 0.001 |
| −27 | −57 | 60 | 3.89 | 0.053 | −21 | −51 | 51 | 4.01 | 0.037 | |
| Superior temporal gyrus right | − | − | − | − | − | 66 | −39 | 18 | 4.81 | 0.013 |
| − | − | − | − | − | − | − | − | − | − | |
| Superior temporal gyrus left | − | − | − | − | − | −63 | −45 | 15 | 5.43 | 0.004 |
| − | − | − | − | − | −54 | −39 | 21 | 4.58 | 0.014 | |
| Frontal eye field right | 42 | −3 | 54 | 5.14 | 0.007 | 54 | 6 | 39 | 6.77 | <0.0001 |
| 45 | 0 | 54 | 4.87 | 0.008 | 57 | 6 | 42 | 6.56 | <0.0001 | |
| Frontal eye field left | −39 | −6 | 51 | 5.22 | 0.006 | −45 | 0 | 48 | 6.13 | <0.0001 |
| −51 | −3 | 48 | 5.82 | 0.001 | −54 | 6 | 33 | 5.94 | 0.001 | |
| Supplementary eye field (SEF)right | 0 | −3 | 63 | 4.29 | 0.026 | 3 | 6 | 54 | 5.74 | 0.003 |
| − | − | − | − | − | −9 | 15 | 45 | 4.24 | 0.025 | |
| Supplementary eye field (SEF)left | 0 | −3 | 63 | 4.29 | 0.026 | 3 | 6 | 54 | 5.74 | 0.003 |
| − | − | − | − | − | −9 | 15 | 45 | 4.24 | 0.025 | |
| Putamen right | 24 | 9 | 3 | 4.24 | 0.017 | 21 | 15 | −9 | 6.15 | 0.001 |
| − | − | − | − | − | − | − | − | − | − | |
| Putamen left | −21 | 6 | 0 | 4.39 | 0.023 | −9 | 12 | 6 | 6.64 | <0.0001 |
| − | − | − | − | − | − | − | − | − | ||
| Cerebellum Vermis (X) | − | − | − | − | − | 3 | −57 | −39 | 6.38 | 0.001 |
| − | − | − | − | − | − | − | − | − | − | |
| Cerebellum Vermis (VIII) | − | − | − | − | − | −3 | −69 | −33 | 4.91 | 0.013 |
| − | − | − | − | − | − | − | − | − | − | |
| Cerebellum Vermis (V)patients:(VI) | 9 | −69 | −9 | 6.08 | 0.001 | − | − | − | − | − |
| 6 | −72 | −18 | 7.98 | <0.0001 | − | − | − | − | − | |
| Cerebellum Flocculus right (X) | − | − | − | − | − | 21 | −39 | −51 | 6.45 | <0.001 |
| − | − | − | − | − | − | − | − | − | − | |
| Cerebellum Flocculus left (X) | − | − | − | − | − | −21 | −39 | −48 | 5.47 | 0.003 |
| − | − | − | − | − | −18 | −45 | −51 | 3.71 | 0.059 | |
| Cerebellum posterior lobe right (VI) | − | − | − | − | − | 12 | −72 | −21 | 8.92 | <0.001 |
| − | − | − | − | − | − | − | − | − | − | |
| Cerebellum posterior lobe left (VI) | − | − | − | − | − | −12 | −75 | −18 | 5.51 | <0.001 |
| − | − | − | − | − | − | − | − | − | − | |
| Cerebellum anterior lobe right (V) | − | − | − | − | − | 30 | −54 | −36 | 5.25 | 0.007 |
| − | − | − | − | − | − | − | − | − | − | |
| Cerebellum anterior lobe left (V) | − | − | − | − | − | −21 | −42 | −30 | 3.68 | 0.062 |
| − | − | − | − | − | − | − | − | − | − | |
The table shows the results of regression analysis of the velocity on the BOLD signal (Blood Oxygen Level Dependency) in patients and healthy subjects. The significance threshold was set at T = 3.5, family wise error correction (FWE) and small volume correction (SVC) of 10 mm sphere, t-values and P-values are depicted, and x, y and z (mm) refer to the coordinates defined by the Montreal Neurological Institute (MNI).
Figure 1Activated regions revealed by the ANOVA and the regression analysis.
Red or blue blobs in the ANOVA represent the calculated main effect (patients > controls and vice versa). For both contrasts family wise error correction at the p = 0.05 level was applied; Condition A: continuous target presentation, Condition B: target blanking. Bottom: Exemplarily the cerebellum during condition B is depicted.
Significant main effects and interactions of the ANOVA.
| main effect | x | y | z | t-value | P (FWE) |
| V5 right | 48 | −63 | 3 | 9.29 | <0.001 |
| V5 left | −45 | −60 | 3 | 5.04 | 0.018 |
| Putamen right | 21 | 12 | 3 | 6.44 | <0.001 |
|
| |||||
| Vermis (Uvula) | 0 | −72 | −42 | 5.96 | <0.0001 |
|
| |||||
| V5 right | 48 | −63 | 3 | 8.22 | <0.001 |
| V5 left | −45 | −60 | 3 | 4.53 | 0.127 |
| Putamen right | 21 | 9 | 3 | 6.37 | <0.001 |
The table shows the main effect of group and the interaction of group x velocity as revealed by ANOVA. The significance threshold was set at T = 4.78 family wise error correction (FWE), with one exception: activation difference (interaction group x velocity) in V5 left felt just below that threshold. P and t-values are depicted, and x, y and z (mm) refer to the coordinates defined by the Montreal Neurological Institute (MNI).
Smooth pursuit eye movement (SPEM): velocity and gain.
| SPEM VelocitySPEM Gain | Patients | Controls | ||
| SPEM Velocity | SPEM Gain | SPEM Velocity | SPEM Gain | |
|
| ||||
|
| 4.30 (1.05) | 0.86 (0.21) | 4.39 (1.80) | 0.88 (0.36) |
|
| 8.86 (2.32) | 0.89 (0.23) | 9.47 (2.06) | 0.95 (0.21) |
|
| 13.48 (3.81) | 0.90 (0.24) | 13.85 (3.60) | 0.92 (0.24) |
|
| 17.79 (3.11) | 0.89 (0.17) | 18.38 (5.06) | 0.92 (0.25) |
|
| ||||
|
| 3.70 (1.64) | 0.74 (0.33) | 4.17 (0.93) | 0.83 (0.19) |
|
| 6.62 (2.38) | 0.66 (0.24) | 6.86 (2.35) | 0.69 (0.23) |
|
| 9.90 (3.81) | 0.66 (0.25) | 10.65 (4.11) | 0.71 (0.27) |
|
| 11.50 (3.11) | 0.58 (0.16) | 12.58 (5.34) | 0.63 (0.27) |
Mean smooth pursuit eye movement (SPEM) – gain values and corresponding velocities and saccadic frequencies with standard deviations during the event interval of 1000 ms in conditions A and B. There were no significant differences between the patients and the healthy subjects for any parameter.